Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting"

Anders Abildgaard; Cindy Søndersø Knudsen; Lise Nørkjær Bjerg; Sten Lund; Julie Støy

doi:10.1515/cclm-2022-0915

Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting"

Anders Abildgaard^*, Cindy Søndersø Knudsen, Lise Nørkjær Bjerg, Sten Lund, Julie Støy

^*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

Original language	English
Journal	Clinical Chemistry and Laboratory Medicine
Volume	61
Issue	1
Pages (from-to)	e8–e10
Number of pages	3
ISSN	1434-6621
DOIs	https://doi.org/10.1515/cclm-2022-0915
Publication status	Published - 1 Jan 2023

Keywords

HbA
analytical performance
point of care testing
Point-of-Care Systems
Humans
Glycated Hemoglobin A/analysis

Access to Document

10.1515/cclm-2022-0915

Cite this

Abildgaard, A., Knudsen, C. S., Bjerg, L. N., Lund, S., & Støy, J. (2023). Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting". Clinical Chemistry and Laboratory Medicine, 61(1), e8–e10. https://doi.org/10.1515/cclm-2022-0915

Abildgaard, Anders ; Knudsen, Cindy Søndersø ; Bjerg, Lise Nørkjær et al. / Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting". In: Clinical Chemistry and Laboratory Medicine. 2023 ; Vol. 61, No. 1. pp. e8–e10.

@article{ca9be1c4779b40cca1017681b3c1818a,

title = "Reply to letter from Mayfield et al. regarding {"}Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage{\texttrademark} HbA1c POCT instrument in a true clinical setting{"}",

keywords = "HbA, analytical performance, point of care testing, Point-of-Care Systems, Humans, Glycated Hemoglobin A/analysis",

author = "Anders Abildgaard and Knudsen, {Cindy S{\o}nders{\o}} and Bjerg, {Lise N{\o}rkj{\ae}r} and Sten Lund and Julie St{\o}y",

year = "2023",

month = jan,

day = "1",

doi = "10.1515/cclm-2022-0915",

language = "English",

volume = "61",

pages = "e8–e10",

journal = "Clinical Chemistry and Laboratory Medicine",

issn = "1434-6621",

publisher = "Walter de Gruyter GmbH",

number = "1",

}

Abildgaard, A , Knudsen, CS, Bjerg, LN, Lund, S & Støy, J 2023, 'Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting"', Clinical Chemistry and Laboratory Medicine, vol. 61, no. 1, pp. e8–e10. https://doi.org/10.1515/cclm-2022-0915

Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting". / Abildgaard, Anders ; Knudsen, Cindy Søndersø; Bjerg, Lise Nørkjær et al.
In: Clinical Chemistry and Laboratory Medicine, Vol. 61, No. 1, 01.01.2023, p. e8–e10.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

TY - JOUR

T1 - Reply to letter from Mayfield et al. regarding "Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA1c POCT instrument in a true clinical setting"

AU - Abildgaard, Anders

AU - Knudsen, Cindy Søndersø

AU - Bjerg, Lise Nørkjær

AU - Lund, Sten

AU - Støy, Julie

PY - 2023/1/1

Y1 - 2023/1/1

KW - HbA

KW - analytical performance

KW - point of care testing

KW - Point-of-Care Systems

KW - Humans

KW - Glycated Hemoglobin A/analysis

U2 - 10.1515/cclm-2022-0915

DO - 10.1515/cclm-2022-0915

M3 - Comment/debate/letter to the editor

C2 - 36281702

SN - 1434-6621

VL - 61

SP - e8–e10

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

IS - 1

ER -